Digital Health and AI in Low- and Middle-Income Countries
By Sumona Bose
February 21, 2024
Introduction
Rising rates of non-communicable diseases (NCDs) pose a significant threat to healthcare systems in low- and middle-income countries. However, the advent of digital technology offers a glimmer of hope in effectively addressing this growing burden. With two-thirds of the world’s population subscribed to mobile services and the increasing accessibility of connectivity, the use of digital solutions and applications has the potential to transform health systems from reactive to proactive and even preventive.
One of the key advancements in digital health is the integration of artificial intelligence (AI). By leveraging AI, health systems can become more predictive, detecting risk factors and enabling healthcare professionals to respond faster in preventing diseases. However, the rapid growth of digital health has also brought about challenges. The proliferation of digital health apps in both the public and private sectors has led to competition and overlap, while the collection and analysis of digital data remain fragmented, leaving some populations behind.
The Promise of Digital Health and AI in Preventive Care
To address these challenges, the Broadband Commission for Sustainable Development, established in 2010, has been at the forefront of advocating for the transformative impact of broadband technologies in healthcare. Its working group on digital and AI in health, co-chaired by the Novartis Foundation and industry leaders such as Nokia, Intel, and Microsoft, has conducted extensive research to identify common challenges and develop a framework for supporting digital health solutions.
The working group has identified six building blocks for digital health systems. These include formulating and executing a national digital health strategy, creating policy and regulatory frameworks that support innovation while ensuring security and privacy, ensuring access to digital infrastructure, promoting interoperability of digital health system components, establishing effective partnerships, and securing adequate financing.
Figure 1: Six building blocks for digital health systems.
Conclusion
By implementing these building blocks, countries can overcome the challenges associated with digital health and AI integration. Coordinated efforts, capacity building, and sustainable financing are crucial in harnessing the full potential of digital technology to improve healthcare outcomes in low- and middle-income countries (LMICs).
As the world continues to grapple with the burden of NCDs, we must embrace the opportunities presented by digital health and AI. By doing so, we can aid healthcare systems, empower healthcare professionals, and ultimately improve the health and well-being of populations in even the most resource-constrained settings.
💡 Did you know that Toombak use is a leading risk factor for oral cancer in East Africa?
A recent scoping review sheds light on the shocking prevalence of oral cancer in the region, emphasising the urgent need for public health interventions and improved early detection strategies. Enhancing awareness around risk factors like Toombak, tobacco, and alcohol for tackling this growing health crisis.
Curious about the key insights and their implications for health economics? Look into the full article to find out more!
🚨 Are you still reacting to pharmaceutical patent expirations with layoffs and litigation, or are you ready to engineer a strategy that turns the patent cliff into your next competitive edge?
Patent expirations don’t have to derail your pharma portfolio. Learn how to outmaneuver generics and transform challenges into advantages. Dive into our latest insights and take control today.
🚀 Are we on the verge of a breakthrough in diabetes medication accessibility?
The latest updates to the Pharmaceutical Benefits Scheme (PBS) are set to transform type 2 diabetes management by expanding access to essential medicines like empagliflozin and streamlining the prescribing process for glucagon-like peptide 1 receptor agonists (GLP-1 RAs). These changes not only prioritize equity for high-risk populations but also align with global trends in cost-effective healthcare.
Dive deeper into how these revisions could reshape diabetes care and promote better health outcomes for all.
When you partner with Syenza, it’s like a Nuclear Fusion.
Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in
health policy, health economics, systems analysis, public finance, business, and project management.
You’ll also feel our high-impact global and local perspectives with cultural intelligence.